Abiopharma

C3.AI, INC. (AI)

Symbol	AI
Name	C3.AI, INC.
Sector	TECHNOLOGY
Region	North America
Industry	Computer Software: Prepackaged Software
Address	1300 SEAPORT BOULEVARD,SUITE 500, REDWOOD CITY, California, 94063, United States
Telephone	+1 650 503-2200
Fax	—
Email	—
Website	https://www.c3.ai
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001577526
Description	C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type; C3 AI Applications, include a large and growing family of industry-specific and application-specific turnkey AI solutions that can be immediately installed and deployed; and C3.ai Ex Machina, analytics for applying data science to every-day business decisions. Additional info from NASDAQ: C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type; C3 AI Applications, include a large and growing family of industry-specific and application-specific turnkey AI solutions that can be immediately installed and deployed; and C3.ai Ex Machina, analytics for applying data science to every-day business decisions.

2026-07-17 20:31

(35% Negative) C3.AI, INC. (AI) Announces Update on Collaboration with A Common Stock

2026-07-16 20:41

Director Hyten John E. 🔴 sold 2.5K shares of C3.ai, Inc. (AI) at $9.14 Transaction Date: Jul 15, 2026 | Filing ID: 000087

2026-07-16 20:40

Director SIEBEL THOMAS M 🟡 adjusted position in 462.6K shares (3 derivative) of C3.ai, Inc. (AI) at $9.32 ($6.6M) Transaction Date: Jul 14, 2026 | Filing ID: 000085

2026-07-02 21:25

Ehikian Stephen Bradley 🟡 adjusted position in 23.0K shares of C3.ai, Inc. (AI) at $9.45 Transaction Date: Jun 30, 2026 | Filing ID: 000083

2026-06-30 21:10

📋 HITESH LATH (OFFICER) plans to sell 49K shares of C3 AI INC (at $8.77 each, total $426K) Filed: Jun 30, 2026 | ID: 046294

2026-06-22 13:00

C3 AI Board Member Jim Hagemann Snabe Appointed European Commission Special Envoy for Industrial AI

2026-06-17 23:52

Lath Hitesh 🟡 adjusted position in 34.2K shares (3 derivative) of C3.ai, Inc. (AI) at $10.95 Transaction Date: Jun 15, 2026 | Filing ID: 000067

2026-06-17 23:51

Director Hyten John E. 🔴 sold 2.5K shares of C3.ai, Inc. (AI) at $11.03 Transaction Date: Jun 15, 2026 | Filing ID: 000065

2026-06-16 18:36

📋 HITESH LATH (OFFICER) plans to sell 34K shares of C3.AI, INC. (at $10.95 each, total $375K) Filed: Jun 16, 2026 | ID: 043500

2026-06-16 00:04

Director SIEBEL THOMAS M 🟡 adjusted position in 495.6K shares (2 derivative) of C3.ai, Inc. (AI) at $11.11 ($7.4M) Transaction Date: Jun 11, 2026 | Filing ID: 000060